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Abstract
Background—Because eosinophilic esophagitis (EoE) causes dysphagia, esophageal narrowing, 
and strictures, it could result in low body mass index (BMI), but there are few data assessing this.
Aim—To determine whether EoE is associated with decreased BMI.
Methods—We conducted a prospective study at the University of North Carolina from 2009–
2013 enrolling consecutive adults undergoing outpatient EGD. BMI and endoscopic findings were 
recorded. Incident cases of EoE were diagnosed per consensus guidelines. Controls had either 
reflux or dysphagia, but not EoE. BMI was compared between cases and controls and by 
endoscopic features.
Results—Of 120 EoE cases and 297 controls analyzed, the median BMI was lower in EoE cases 
(25 kg/m2 vs. 28 kg/m2, p=0.002). BMI did not differ by stricture presence (26 kg/m2 vs. 26 
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kg/m2, p=0.05) or by performance of dilation (26 kg/m2 vs. 27 for undilated; p=0.16). However, 
BMI was lower in patients with narrow caliber esophagus (24 kg/m2 vs. 27, p<0.001). EoE 
patients with narrow caliber esophagus also had decreased BMI compared to controls with narrow 
caliber esophagi (24 kg/m2 vs. 27, p=0.001). On linear regression after adjustment for age, race, 
and gender, narrowing decreased BMI by 2.3 kg/m2 [95% CI −4.1, −0.6].
Conclusions—BMI is lower in EoE cases compared to controls, and esophageal narrowing, but 
not focal stricture, is associated with a lower BMI in patients with EoE. Weight loss or low BMI in 
a patient suspected of having EoE should raise concern for esophageal remodeling causing narrow 
caliber esophagus.
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Introduction
Eosinophilic Esophagitis (EoE) is a condition of chronic immune-mediated inflammation of 
the esophagus characterized by dysphagia and other symptoms of esophageal dysfunction 
and the presence of eosinophils on tissue evaluation [1–3]. Given the structural remodeling 
of the esophagus such as narrowing, strictures, and rings that occurs in EoE as a 
consequence of chronic inflammation [4–10], there is concern EoE could decrease oral 
intake, resulting in weight loss and malnutrition. Indeed, in infants and children, poor 
growth and feeding intolerance are common symptoms of EoE [11–14], but this has not been 
examined in detail in adults.
To date, research on BMI in EoE patients at the time of diagnosis has been sparse. As 
dysphagia is the most commonly reported symptom in adolescents and adults with EoE [1–
3,15–18], it is not surprising that many patients will modify their diet and their eating habits 
by avoiding foods that stick, eating slowly, and chewing thoroughly [19,20]. However, the 
impact of symptoms and these avoidance/modification behaviors on BMI are not known. It 
is also not known if a low BMI is more common at diagnosis in EoE or if features of EoE 
correlate with BMI.
The aim of this study was to assess whether incident EoE is associated with a decreased 
BMI. Additionally, we aimed to determine if specific clinical and endoscopic features of 
EoE were associated with decreased BMI. We hypothesized that EoE patients would have 
diminished BMI compared to non-EoE controls and that the decrease in BMI would be of 
greater magnitude in the presence of structural remodeling of the esophagus (i.e rings, 
strictures, narrow esophageal caliber).
Methods
We conducted a prospective cohort study at the University of North Carolina from 2009 to 
2013. Details of the protocol have been previously reported [21–24]. In brief, consecutive 
adult patients (age 18–80 years) undergoing routine outpatient esophagogastroduodenoscopy 
(EGD) were approached if they had symptoms suggestive of esophageal dysfunction (e.g., 
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dysphagia, food impaction, heartburn, reflux, chest pain). Subjects provided informed 
consent and were enrolled before the endoscopy. Subjects were excluded if they had a 
known (prevalent) diagnosis of EoE or other eosinophilic gastrointestinal disorder, 
gastrointestinal bleeding, active anticoagulation, known esophageal cancer, prior esophageal 
surgery, known esophageal varices, medical instability or comorbidities precluding 
enrollment in the opinion of the endoscopist, or an inability to read or understand the 
consent form. This study was approved by the UNC Institutional Review Board.
Cases were diagnosed with incident EoE if they met consensus guidelines [1–3]. 
Specifically, they were required to have at least one typical symptom of esophageal 
dysfunction; at least 15 eosinophils per high-power field (eos/hpf) on esophageal biopsy 
persisting after an 8-week PPI trial (20–40 mg twice daily of any of the available agents, 
prescribed at the discretion of the clinician); and other causes of esophageal eosinophilia 
excluded. Of note, these were incident EoE cases, such that case/control status could not be 
definitively assigned until after the PPI trial and repeat EGD. Controls were subjects who, 
after endoscopy and biopsy, did not meet the clinical or histologic criteria for EoE. Controls 
were further subdivided based on their chief presenting symptom into dysphagia controls 
and reflux controls. Subjects with PPI-responsive esophageal eosinophilia were not included 
in the present analysis.
Clinical data were collected using a standardized case report form. Items recorded included 
demographics, anthropomorphic features (height and weight for calculation of BMI), 
symptoms, concomitant atopic diseases, indications for endoscopy, and endoscopic findings. 
Of note, strictures were defined as a focal area of reduced luminal diameter in the esophagus 
of any length with adjoined esophagus of normal caliber, while narrowing was defined as a 
diffuse decrease in luminal diameter throughout the course of the esophagus. During 
endoscopy, five research-protocol esophageal biopsies were obtained (two from the 
proximal, one from the mid, and two from the distal esophagus) to maximize EoE diagnostic 
sensitivity [25,26]. Gastric and duodenal biopsies were also collected for research purposes 
to exclude concomitant eosinophilic gastroenteritis. Esophageal eosinophil counts were 
quantified by the study pathologists using our previously validated methods [27]. Briefly, 
slides were masked to case/control status, digitized, and reviewed with Aperio ImageScope 
(Aperio Technologies, Vista, CA). Five microscopy fields from each of the five biopsies 
were examined to determine the maximum eosinophil density (eosinophils/mm2 [eos/mm2]). 
So histologic results could be compared with prior studies, eosinophils density was 
standardized to a high powered field (hpf) of 0.24 mm2 and reported as eosinophils per hpf 
(eos/hpf) [12].
Statistical analysis
Descriptive statistics were used to summarize baseline clinical, endoscopic, and histologic 
characteristics of the cases and controls. Non-parametric testing (Wilcoxon signed rank) was 
used to compare medians, as all continuous variables of interest were non-normally 
distributed. Proportions were compared with χ2 testing. BMI was compared between EoE 
cases and controls (both reflux and dysphagia controls) as well as among EoE cases and 
controls with endoscopic features likely to impair swallowing (e.g. narrowing, strictures, 
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dilation). BMI values were stratified into 4 ranges corresponding with standard medical 
definitions of weight: <18.5 kg/m2 (underweight), 18.5–24.9 kg/m2 (normal weight), 25–
29.9 kg/m2 (overweight), and ≥30 kg/m2 (obese). Logistic regression models were 
constructed to assess the odds of obesity in patients based on their clinical features, while 
controlling for potentially confounding variables. Generalized linear models were 
constructed to analyze the change in BMI caused by the presence of selected endoscopic 
features.
Results
A total of 120 EoE cases and 297 controls were included. Compared with controls, EoE 
patients were more likely to be younger (median 37 years old vs. 55; p<0.0001), male (63% 
vs. 38%; p<0.0001), white (93% vs. 79%; p=0.0003), and have an atopic disorder (70% vs. 
60%; p=0.046). (Table 1) Endoscopic findings typical of EoE were more common in the 
EoE group. For example, EoE cases were more likely to have strictures (28% vs 19%; 
p=0.03), rings (82% vs. 13%; p<0.0001), or esophageal narrowing (34% vs. 4%; p<0.0001). 
Most patients with narrowing (31 of 54, 57%) received dilation, and EoE patients with 
narrowing underwent fewer dilations than controls with narrowing (49% vs 85%, p = 0.02). 
Patients with stricture were also likely to receive dilation (77 of 89, 87%), and EoE patients 
with strictures were underwent fewer dilations than controls with strictures (74% vs 95%, p 
= 0.005). The median peak eosinophil count at diagnosis was 104 (interquartile range (IQR) 
124) eos/hpf in EoE cases compared with 0 (IQR 2) eos/hpf among controls (p<0.0001).
The median BMI was lower among EoE patients than controls (25 kg/m2, IQR 5 vs. 28 
kg/m2, IQR 8; p=0.002). The distribution of patients among BMI categories was shifted 
downward in EoE cases with 17% obese compared to 34% of controls, and 47% normal 
weight compared to 32% of controls (Figure 1). This relationship persisted after adjusting 
for age, race and gender (OR for obesity in EoE patients = 0.54 [0.30–0.99]). The dysphagia 
controls and reflux controls did not differ on median BMI (27 kg/m2, IQR 8 vs 28 kg/m2, 
IQR 9; p=0.07) or on the distribution of BMI categories. (Table 2) The median BMI among 
EoE cases differed significantly from reflux controls (p< 0.0001) and dysphagia controls 
(p=0.007). The distribution of BMI categories differed significantly between EoE cases and 
reflux controls, but did not reach significance when comparing EoE cases to dysphagia 
controls (Table 2).
The presence of a stricture at baseline did not impact BMI in the total study population 
(median BMI with stricture 26 kg/m2, IQR 7 vs. 26 kg/m2, IQR 8 without stricture; p=0.05). 
EoE patients without strictures had a lower median BMI compared to controls without 
strictures (25 kg/m2, IQR 5 vs. 27 kg/m2, IQR 8; p=0.001), and were less likely to be obese 
(20% vs 37%) and more likely to be normal weight (47% vs 31%; p = 0.001) (Figure 2a). 
The pattern was similar among EoE patients with strictures compared to controls with 
strictures, but did not reach statistical significance (median BMI 25 kg/m2, IQR 6 vs. 27 
kg/m2, IQR 7; p=0.07; 9% obese vs 24% and 47% normal weight vs 38%, p = 0.36) (Figure 
2b). On linear regression after adjustment for age, race, and gender, the presence of a 
stricture at baseline did not significantly impact BMI in the population as a whole (−1.0 
kg/m2 [95% CI −2.5, 0.4]) or in patients with EoE (−0.7 kg/m2 [95% CI −2.6, 1.2]).
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The presence of esophageal narrowing reduced BMI in the total study population (median 
BMI with narrowing 24 kg/m2, IQR 5 vs. 27 kg/m2, IQR 8 without; p=0.0002). The median 
BMI in EoE patients without narrowing did not differ statistically from controls without 
narrowing (26 kg/m2, IQR 7 vs. 27 kg/m2, IQR 8; p=0.07). There was no statistical 
difference in the frequency of obesity (24% vs 34%) or normal weight (42% vs 32%; p = 
0.31) (Figure 3a). However, among patients with narrowing, EoE patients had a lower 
median BMI than controls with narrowing (24 kg/m2, IQR 5 vs. 27 kg/m2, IQR 5; p=0.001). 
EoE patients with esophageal narrowing were less likely to be obese (2% vs 38%) and more 
likely to be normal weight (56% vs 31%, p = 0.004) (Figure 3b). On linear regression after 
adjustment for age, race, and gender, the presence of narrowing at baseline significantly 
decreased the BMI in the population as a whole (−2.3 kg/m2 [95% CI −4.1, −0.6]) and in 
patients with EoE (−2.6 kg/m2 [95% CI −4.3, −0.8]).
Discussion
EoE is associated with dysphagia and endoscopic abnormalities such as esophageal 
strictures and narrowing, particularly in adolescents and adults. However, little is known 
about the association of these features with BMI. In this prospective study that collected 
clinical, endoscopic, histologic, and anthropomorphic data on incident cases of EoE and 
non-EoE controls, we evaluated differences in BMI and the impact of endoscopic fibrotic 
changes on BMI. We found that EoE patients have a lower BMI than non-EoE controls, both 
when BMI is viewed as a continuous variable and when categorized into standard ranges 
from underweight to obese. On further examination of the esophageal characteristics most 
likely to produce reduced BMI, we found that the presence of esophageal strictures did not 
impact BMI, but narrowing reduced BMI by more than 2 kg/m2 regardless of EoE status. 
However, unlike strictures, which were present in about 20% of our controls, narrowing is 
more specific to EoE with one-third of EoE patients having a narrowed esophagus while 
only 4% of non-EoE controls demonstrated this finding. This may indicate that lower BMI 
in EoE patients should raise clinical suspicion for esophageal narrowing. However, a low 
BMI, by itself, is not specific enough to aid in the diagnosis of EoE.
While weight loss is a common symptom in gastrointestinal conditions and failure to thrive, 
poor growth, or feeding intolerance can be symptoms of EoE in infants and young children 
[11–14], a paucity of data exists on BMI in EoE. Liacouras and colleagues found that out of 
247 children enrolled in a study evaluating elimination diet to treat EoE, only 5 had weights 
< 5th percentile on the appropriate growth curve [13]. Von Arnim and colleagues evaluated 
for clinical markers of EoE in a retrospective study involving 43 adults and similarly found 
no significant difference in weight loss between EoE and GERD patients. However, only 4 
patients (1 with EoE) reported weight loss [28]. More recently, a low BMI has been 
identified in patients with concomitant EoE and connective tissue disease [29], and a higher 
BMI has been associated with EoE patients who are vitamin deficient [30]. We were unable 
to find any studies assessing BMI in EoE cases and controls, stratified by endoscopic fibrotic 
findings, that would be directly comparable to our results.
When interpreting data from this study, there are potential limitations to consider. Because 
reflux is associated with obesity and is a common cause of dysphagia, patients referred for 
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dysphagia which was not caused by EoE may be more likely to be obese. This may elevate 
the BMI of the non-EoE controls relative to the general population, though the data here are 
still representative of a group of patients referred for endoscopy. In addition, the study was 
performed at a single center and did not include children, so results cannot be generalized to 
pediatric populations. Heights and weights were self-reported by the participant. However, 
potential bias stemming from self-reporting would presumably be similar in both case and 
control groups, especially among groups with like symptoms, such as the dysphagia control 
group. Our endoscopic measures of fibrosis (stricture and narrowing) were recorded as per 
endoscopist report, and we do not have data on severity of stricture or length of narrowing, 
and this may introduce heterogeneity into these categories. Finally, as this study was a cross-
sectional analysis, we do not have outcomes data on whether successful treatment of EoE 
caused a change in BMI.
Our study also has a number of strengths. The study was prospective and focused on a 
population of well-characterized incident EoE cases and non-EoE controls. All patients were 
evaluated at the time of initial presentation, meaning that the comparison of BMI between 
cases and controls could not be confounded by therapy directed at EoE. It is the only study 
to date to specifically evaluate BMI between EoE and non-EoE controls and to examine the 
role of endoscopic fibrotic features on BMI. Uniform methods were used for case-control 
identification, baseline data collection, and endoscopic evaluation, and these data were 
collected before EoE diagnosis was known.
In conclusion, in this large prospective study, EoE case status was associated with decreased 
BMI compared with controls. However, BMI for most EoE patients was not in the 
underweight range, and a low BMI was not specific enough to be helpful for diagnosis of 
EoE. Esophageal narrowing may drive decreased BMI, and weight loss or low BMI in a 
patient suspected of having EoE should raise concern for esophageal remodeling causing 
narrow caliber esophagus. Evaluation in this setting should include barium swallow which 
has previously been shown to be a sensitive test for esophageal narrowing in EoE [31,32]. 
Further research should assess whether treatment of EoE and resolution of esophageal 
narrowing cause changes to BMI.
Acknowledgments
Financial Support: This research was funded by T32 DK07634 (WAW; TMR; SE), K23DK090073 (ESD), 
K24DK100548 (NJS), and R01DK101856 (ESD) from the National Institutes of Health.
Abbreviations
BMI body mass index
EoE eosinophilic esophagitis
eos eosinophils
EGD esophagogastroduodenoscopy
hpf high powered field
Wolf et al. Page 6
Dig Dis Sci. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
IQR interquartile range
PPI proton pump inhibitor
SD standard deviation
References
1. Dellon ES, Gonsalves N, Hirano I, et al. ACG clinical guideline: Evidenced based approach to the 
diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J 
Gastroenterol. 2013; 108:679–692. quiz 693. [PubMed: 23567357] 
2. Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a 
systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 
2007; 133:1342–1363. [PubMed: 17919504] 
3. Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus 
recommendations for children and adults. J Allergy Clin Immunol. 2011; 128:3–20. e26. quiz 21–
22. [PubMed: 21477849] 
4. Cheng E, Souza RF, Spechler SJ. Tissue remodeling in eosinophilic esophagitis. Am J Physiol 
Gastrointest Liver Physiol. 2012; 303:G1175–1187. [PubMed: 23019192] 
5. Eluri S, Runge TM, Cotton CC, et al. The extremely narrow-caliber esophagus is a treatment-
resistant subphenotype of eosinophilic esophagitis. Gastrointest Endosc. 2016; 83:1142–1148. 
[PubMed: 26608127] 
6. Hirano I, Aceves SS. Clinical implications and pathogenesis of esophageal remodeling in 
eosinophilic esophagitis. Gastroenterol Clin North Am. 2014; 43:297–316. [PubMed: 24813517] 
7. Kim HP, Vance RB, Shaheen NJ, Dellon ES. The prevalence and diagnostic utility of endoscopic 
features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol. 2012; 10:988–
996. e985. [PubMed: 22610003] 
8. Lee J, Huprich J, Kujath C, et al. Esophageal diameter is decreased in some patients with 
eosinophilic esophagitis and might increase with topical corticosteroid therapy. Clin Gastroenterol 
Hepatol. 2012; 10:481–486. [PubMed: 22309879] 
9. Runge TM, Eluri S, Cotton CC, et al. Outcomes of Esophageal Dilation in Eosinophilic Esophagitis: 
Safety, Efficacy, and Persistence of the Fibrostenotic Phenotype. Am J Gastroenterol. 2016; 
111:206–213. [PubMed: 26753894] 
10. Vasilopoulos S, Murphy P, Auerbach A, et al. The small-caliber esophagus: an unappreciated cause 
of dysphagia for solids in patients with eosinophilic esophagitis. Gastrointest Endosc. 2002; 
55:99–106. [PubMed: 11756928] 
11. Assa’ad AH, Putnam PE, Collins MH, et al. Pediatric patients with eosinophilic esophagitis: an 8-
year follow-up. J Allergy Clin Immunol. 2007; 119:731–738. [PubMed: 17258309] 
12. Dellon ES, Aderoju A, Woosley JT, Sandler RS, Shaheen NJ. Variability in diagnostic criteria for 
eosinophilic esophagitis: a systematic review. Am J Gastroenterol. 2007; 102:2300–2313. 
[PubMed: 17617209] 
13. Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 
children. Clin Gastroenterol Hepatol. 2005; 3:1198–1206. [PubMed: 16361045] 
14. Spergel JM, Brown-Whitehorn TF, Beausoleil JL, et al. 14 years of eosinophilic esophagitis: 
clinical features and prognosis. J Pediatr Gastroenterol Nutr. 2009; 48:30–36. [PubMed: 
19172120] 
15. Dellon ES, Gibbs WB, Fritchie KJ, et al. Clinical, endoscopic, and histologic findings distinguish 
eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009; 
7:1305–1313. quiz 1261. [PubMed: 19733260] 
16. Kapel RC, Miller JK, Torres C, Aksoy S, Lash R, Katzka DA. Eosinophilic esophagitis: a prevalent 
disease in the United States that affects all age groups. Gastroenterology. 2008; 134:1316–1321. 
[PubMed: 18471509] 
Wolf et al. Page 7
Dig Dis Sci. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
17. Mackenzie SH, Go M, Chadwick B, et al. Eosinophilic oesophagitis in patients presenting with 
dysphagia--a prospective analysis. Aliment Pharmacol Ther. 2008; 28:1140–1146. [PubMed: 
18624788] 
18. Pasha SF, DiBaise JK, Kim HJ, et al. Patient characteristics, clinical, endoscopic, and histologic 
findings in adult eosinophilic esophagitis: a case series and systematic review of the medical 
literature. Dis Esophagus. 2007; 20:311–319. [PubMed: 17617880] 
19. Dellon ES, Liacouras CA. Advances in clinical management of eosinophilic esophagitis. 
Gastroenterology. 2014; 147:1238–1254. [PubMed: 25109885] 
20. Schoepfer AM, Straumann A, Panczak R, et al. Development and validation of a symptom-based 
activity index for adults with eosinophilic esophagitis. Gastroenterology. 2014; 147:1255–1266. 
e1221. [PubMed: 25160980] 
21. Dellon ES, Rusin S, Gebhart JH, et al. Utility of a Noninvasive Serum Biomarker Panel for 
Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study. Am J Gastroenterol. 
2015; 110:821–827. [PubMed: 25781367] 
22. Dellon ES, Rusin S, Gebhart JH, et al. A Clinical Prediction Tool Identifies Cases of Eosinophilic 
Esophagitis Without Endoscopic Biopsy: A Prospective Study. Am J Gastroenterol. 2015; 
110:1347–1354. [PubMed: 26303128] 
23. Dellon ES, Speck O, Woodward K, et al. Markers of eosinophilic inflammation for diagnosis of 
eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a 
prospective study. Clin Gastroenterol Hepatol. 2014; 12:2015–2022. [PubMed: 24993367] 
24. Dellon ES, Speck O, Woodward K, et al. Clinical and endoscopic characteristics do not reliably 
differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients 
undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol. 2013; 108:1854–
1860. [PubMed: 24145677] 
25. Dellon ES, Speck O, Woodward K, et al. Distribution and variability of esophageal eosinophilia in 
patients undergoing upper endoscopy. Mod Pathol. 2015; 28:383–390. [PubMed: 25216228] 
26. Gonsalves N, Policarpio-Nicolas M, Zhang Q, Rao MS, Hirano I. Histopathologic variability and 
endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc. 2006; 64:313–
319. [PubMed: 16923475] 
27. Dellon ES, Fritchie KJ, Rubinas TC, Woosley JT, Shaheen NJ. Inter- and intraobserver reliability 
and validation of a new method for determination of eosinophil counts in patients with esophageal 
eosinophilia. Dig Dis Sci. 2010; 55:1940–1949. [PubMed: 19830560] 
28. von Arnim U, Wex T, Rohl FW, et al. Identification of clinical and laboratory markers for 
predicting eosinophilic esophagitis in adults. Digestion. 2011; 84:323–327. [PubMed: 22075653] 
29. Abonia JP, Wen T, Stucke EM, et al. High prevalence of eosinophilic esophagitis in patients with 
inherited connective tissue disorders. J Allergy Clin Immunol. 2013; 132:378–386. [PubMed: 
23608731] 
30. Slack MA, Ogbogu PU, Phillips G, Platts-Mills TA, Erwin EA. Serum vitamin D levels in a cohort 
of adult and pediatric patients with eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2015; 
115:45–50. [PubMed: 26004426] 
31. Gentile N, Katzka D, Ravi K, et al. Oesophageal narrowing is common and frequently under-
appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther. 
2014; 40:1333–40. [PubMed: 25287184] 
32. Menard-Katcher C, Swerdlow MP, Mehta P, et al. Contribution of Esophagram To The Evaluation 
of Complicated Pediatric Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr. 2015; 61:541–6. 
[PubMed: 25988559] 
Wolf et al. Page 8
Dig Dis Sci. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
BMI distribution in EoE cases and non-EoE controls. P value represents the comparison of 
weight categories between groups.
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Figure 2. 
(A) BMI distribution in EoE cases without strictures and non-EoE controls without 
strictures. (B) BMI distribution in EoE cases with strictures and non-EoE controls with 
strictures. P values represent the comparison of weight categories between groups.
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Figure 3. 
(A) BMI distribution in EoE cases without narrowing and non-EoE controls without 
narrowing. (B) BMI distribution in EoE cases with narrowing and non-EoE controls with 
narrowing. P values represent the comparison of weight categories between groups.
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Table 1
Patient Characteristics
Controls (n = 297) EoE Cases (n = 120) p-value*
Age, median (IQR) 55 (22) 37 (15) <0.0001
White Race, n (%) 234 (79) 112 (93) 0.0003
Male Gender, n (%) 112 (38) 75 (63) <0.0001
Any atopic Disease, n (%) 163 (60) 83 (70) 0.046
 Asthma, n (%) 70 (26) 33 (28) 0.68
 Eczema, n (%) 22 (8) 9 (8) 0.87
 Seasonal allergy, n (%) 136 (50) 74 (63) 0.02
 Food allergy, n (%) 44 (16) 43 (36) <0.0001
Baseline EGD Findings, n (%)
 Normal 59 (20) 3 (3) <0.0001
 Rings 37 (13) 98 (82) <0.0001
 Stricture 55 (19) 34 (28) 0.03
 Narrowing 13 (4) 41 (34) <0.0001
 Furrows 19 (6) 104 (87) <0.0001
 Crepe paper 3 (1) 9 (8) 0.0003
 White plaques 13 (4) 55 (46) <0.0001
 Decreased vascularity 9 (3) 60 (50) <0.0001
 Hiatal hernia 125 (42) 18 (15) <0.0001
 Dilation 95 (32) 39 (33) 0.92
Baseline peak eosinophil count (eos/hpf), median (IQR) 0 (2) 104 (124) <0.0001
*p values presented are the result of Wilcoxon signed rank testing of continuous variables or χ2 testing of categorical variables.
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Table 2
BMI in EoE vs Control Subgroups
EoE
n = 120
Dysphagia Controls
n = 177
Reflux Controls
n = 120
Low (< 18.5 kg/m2) 3 (3) 4 (2) 0 (0)
Normal (18.5–24.9 kg/m2) 56 (47) 61 (34) 35 (29)
Overweight (25–29.9 kg/m2) 41 (34) 60 (34) 36 (30)
Obese (≥30 kg/m2) 20 (17) 52 (29) 49 (41)
p-value* -- 0.06 0.0001
*
compared to EoE group. P-value comparing dysphagia controls to reflux controls = 0.09.
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